Menopause, Estrogens, and Glucose Homeostasis in Women

被引:21
作者
Mauvais-Jarvis, Franck [1 ]
机构
[1] Tulane Univ, Dept Med, Sect Endocrinol & Metab, Hlth Sci Ctr,Sch Med, New Orleans, LA 70118 USA
来源
SEX AND GENDER FACTORS AFFECTING METABOLIC HOMEOSTASIS, DIABETES AND OBESITY | 2017年 / 1043卷
基金
美国国家卫生研究院;
关键词
POSTMENOPAUSAL HORMONE-THERAPY; CONJUGATED EQUINE ESTROGEN; REPLACEMENT THERAPY; INSULIN SENSITIVITY; TRANSDERMAL; 17-BETA-ESTRADIOL; PLASMA-LIPIDS; DOUBLE-BLIND; ELIMINATION; SECRETION; LIPOPROTEINS;
D O I
10.1007/978-3-319-70178-3_11
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Randomized trials suggest that menopausal hormone therapy (MHT) prevents type 2 diabetes. Still, the mechanisms of these antidiabetic effects are a matter of controversy. This chapter provides an analysis of epidemiological and clinical evidence and proposes a mechanism for the effect of menopause and MHT on type 2 diabetes development and prevention. It discusses the beneficial role of estradiol on glucose homeostasis that is lost at menopause and improved by MHT, which delays type 2 diabetes. This chapter aims to reconcile differences among studies of the effect of menopause and MHT formulations on type 2 diabetes and argues that discrepancies arise from physiological differences in methods used to assess glucose homeostasis.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 35 条
[1]   Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus [J].
Andersson, B ;
Mattsson, LA ;
Hahn, L ;
Marin, P ;
Lapidus, L ;
Holm, G ;
Bengtsson, BA ;
Bjorntorp, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (02) :638-643
[2]   The effect of conjugated equine oestrogen on diabetes incidence: The Women's Health Initiative randomised trial [J].
Bonds, DE ;
Lasser, N ;
Qi, L ;
Brzyski, R ;
Caan, B ;
Heiss, G ;
Limacher, MC ;
Liu, JH ;
Mason, E ;
Oberman, A ;
O'Sullivan, MJ ;
Phillips, LS ;
Prineas, RJ ;
Tinker, L .
DIABETOLOGIA, 2006, 49 (03) :459-468
[3]   Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk [J].
Brand, Judith S. ;
van der Schouw, Yvonne T. ;
Onland-Moret, N. Charlotte ;
Sharp, Stephen J. ;
Ong, Ken K. ;
Khaw, Kay-Tee ;
Ardanaz, Eva ;
Amiano, Pilar ;
Boeing, Heiner ;
Chirlaque, Maria-Dolores ;
Clavel-Chapelon, Francoise ;
Crowe, Francesca L. ;
de Lauzon-Guillain, Blandine ;
Duell, Eric J. ;
Fagherazzi, Guy ;
Franks, Paul W. ;
Grioni, Sara ;
Groop, Leif C. ;
Kaaks, Rudolf ;
Key, Timothy J. ;
Nilsson, Peter M. ;
Overvad, Kim ;
Palli, Domenico ;
Panico, Salvatore ;
Quiros, J. Ramon ;
Rolandsson, Olov ;
Sacerdote, Carlotta ;
Sanchez, Maria-Jose ;
Slimani, Nadia ;
Teucher, Birgit ;
Tjonneland, Anne ;
Tumino, Rosario ;
van der A, Daphne L. ;
Feskens, Edith J. M. ;
Langenberg, Claudia ;
Forouhi, Nita G. ;
Riboli, Elio ;
Wareham, Nicholas J. .
DIABETES CARE, 2013, 36 (04) :1012-1019
[4]   Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM [J].
Brussaard, HE ;
Leuven, JAG ;
Frolich, M ;
Kluft, C ;
Krans, HMJ .
DIABETOLOGIA, 1997, 40 (07) :843-849
[5]   EFFECTS OF LOW-DOSES OF TRANSDERMAL 17-BETA-ESTRADIOL ON CARBOHYDRATE-METABOLISM IN POSTMENOPAUSAL WOMEN [J].
CAGNACCI, A ;
SOLDANI, R ;
CARRIERO, PL ;
PAOLETTI, AM ;
FIORETTI, P ;
MELIS, GB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (06) :1396-1400
[6]   Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle G,n,rale de l'Education Nationale (E3N) cohort [J].
de Lauzon-Guillain, B. ;
Fournier, A. ;
Fabre, A. ;
Simon, N. ;
Mesrine, S. ;
Boutron-Ruault, M-C. ;
Balkau, B. ;
Clavel-Chapelon, F. .
DIABETOLOGIA, 2009, 52 (10) :2092-2100
[7]   Effect of postmenopausal hormone therapy on glucose and insulin concentrations [J].
Espeland, MA ;
Hogan, PE ;
Fineberg, SE ;
Howard, G ;
Schrott, H ;
Waclawiw, MA ;
Bush, TL .
DIABETES CARE, 1998, 21 (10) :1589-1595
[8]   Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes [J].
Friday, KE ;
Dong, CP ;
Fontenot, RU .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :48-52
[9]   Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women [J].
Godsland, IF ;
Manassiev, NA ;
Felton, CV ;
Proudler, AJ ;
Crook, D ;
Whitehead, MI ;
Stevenson, JC .
CLINICAL ENDOCRINOLOGY, 2004, 60 (05) :541-549
[10]   INSULIN-RESISTANCE, SECRETION, AND ELIMINATION IN POSTMENOPAUSAL WOMEN RECEIVING ORAL OR TRANSDERMAL HORMONE REPLACEMENT THERAPY [J].
GODSLAND, IF ;
GANGAR, K ;
WALTON, C ;
CUST, MP ;
WHITEHEAD, MI ;
WYNN, V ;
STEVENSON, JC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07) :846-853